| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
25,982 |
22,977 |
$1.88M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
22,036 |
19,827 |
$1.08M |
| 90834 |
Psychotherapy, 45 minutes with patient |
6,033 |
3,739 |
$387K |
| 99215 |
Prolong outpt/office vis |
1,072 |
970 |
$127K |
| X5622 |
|
2,151 |
2,086 |
$103K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,490 |
3,425 |
$97K |
| 90791 |
Psychiatric diagnostic evaluation |
941 |
920 |
$92K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
929 |
905 |
$74K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
802 |
786 |
$55K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
5,158 |
5,086 |
$47K |
| 36415 |
Collection of venous blood by venipuncture |
11,556 |
10,414 |
$32K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
487 |
477 |
$31K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
299 |
287 |
$30K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,166 |
2,078 |
$29K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
341 |
333 |
$25K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
308 |
283 |
$22K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
804 |
784 |
$19K |
| 97811 |
|
710 |
254 |
$18K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
213 |
185 |
$18K |
| 90686 |
|
3,349 |
3,271 |
$18K |
| 97810 |
|
718 |
256 |
$16K |
| 80061 |
Lipid panel |
1,033 |
1,018 |
$13K |
| 84443 |
Thyroid stimulating hormone (TSH) |
642 |
623 |
$10K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
279 |
273 |
$10K |
| 92551 |
|
2,710 |
2,671 |
$10K |
| 90837 |
Psychotherapy, 53 minutes with patient |
80 |
54 |
$10K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,004 |
958 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
952 |
920 |
$8K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,250 |
1,171 |
$7K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
111 |
83 |
$6K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
173 |
170 |
$6K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
161 |
158 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
272 |
266 |
$5K |
| 99188 |
|
679 |
675 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
121 |
119 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
720 |
689 |
$5K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
78 |
74 |
$5K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
165 |
156 |
$3K |
| 0004A |
|
68 |
66 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
73 |
62 |
$2K |
| 0002A |
|
87 |
85 |
$2K |
| 90651 |
|
183 |
175 |
$2K |
| 0001A |
|
105 |
103 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
207 |
155 |
$2K |
| 99173 |
|
2,683 |
2,642 |
$2K |
| 0054A |
|
41 |
41 |
$2K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
12 |
12 |
$2K |
| 96127 |
|
469 |
460 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
38 |
38 |
$1K |
| 99243 |
|
14 |
14 |
$1K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
221 |
215 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
13 |
$1K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
12 |
12 |
$1K |
| 96130 |
|
13 |
12 |
$1K |
| 0071A |
|
29 |
24 |
$991.31 |
| 90656 |
|
83 |
82 |
$961.38 |
| 90715 |
|
113 |
113 |
$941.27 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
67 |
65 |
$859.66 |
| 85018 |
|
502 |
488 |
$858.81 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
167 |
157 |
$705.14 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
26 |
25 |
$665.13 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
82 |
75 |
$637.97 |
| 0072A |
|
14 |
14 |
$588.53 |
| 80053 |
Comprehensive metabolic panel |
54 |
53 |
$563.60 |
| 36416 |
|
141 |
119 |
$442.31 |
| 96136 |
|
13 |
12 |
$401.23 |
| 81001 |
|
167 |
151 |
$364.02 |
| 82728 |
|
26 |
25 |
$343.89 |
| 71046 |
Radiologic examination, chest; 2 views |
13 |
13 |
$340.88 |
| 87081 |
|
202 |
195 |
$250.11 |
| G0008 |
Administration of influenza virus vaccine |
99 |
98 |
$221.01 |
| 86803 |
|
13 |
13 |
$191.24 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
15 |
14 |
$167.66 |
| 99443 |
|
29 |
29 |
$156.15 |
| 85027 |
|
12 |
12 |
$82.92 |
| 90716 |
|
12 |
12 |
$0.00 |
| 99000 |
|
25 |
25 |
$0.00 |
| 90723 |
|
26 |
26 |
$0.00 |
| 90647 |
|
16 |
15 |
$0.00 |
| 81003 |
|
31 |
27 |
$0.00 |
| 99442 |
|
17 |
16 |
$0.00 |
| 90734 |
|
160 |
160 |
$0.00 |
| 90670 |
|
67 |
66 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
150 |
122 |
$0.00 |
| 90707 |
|
12 |
12 |
$0.00 |
| 90681 |
|
12 |
12 |
$0.00 |
| 90633 |
|
74 |
73 |
$0.00 |
| 87210 |
|
29 |
28 |
$0.00 |
| 81025 |
|
13 |
12 |
$0.00 |